Vivos Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Vivos Therapeutics, Inc. (VVOS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 0.00 shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.97M shares, a 103.72% increase from fiscal 2021.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 969.00K shares, a 125.87% increase from fiscal 2020.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 429.00K shares, a 14.77% decline from fiscal 2019.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 503.33K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-14 | 0.00 shares 10-Q · filed 2026-08-14 | |||
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-19 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-14 | 0.00 shares 10-Q · filed 2025-11-19 | ||
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-08-14 | 0.00 shares 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-20 | ||||
| 2024-09-30 | 105.00K shares 10-Q · filed 2025-11-19 | ||||
| 2022-12-31 | 1.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 1.42M shares derived: sum of 2 quarters · filed 2023-03-30 | 1.68M shares derived: sum of 3 quarters · filed 2023-03-30 | 1.97M shares 10-K · filed 2023-03-30 | |
| 2022-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | 280.00K shares derived: sum of 2 quarters · filed 2022-12-20 | 570.00K shares 10-Q · filed 2022-12-20 | 570.00K shares derived: sum of 4 quarters · filed 2023-03-30 | |
| 2022-06-30 | 265.00K shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-12-20 | 555.00K shares 10-Q · filed 2022-12-20 | 555.00K shares derived: sum of 3 quarters · filed 2023-03-30 | 1.09M shares derived: sum of 4 quarters · filed 2023-03-30 | |
| 2022-03-31 | 290.00K shares 10-Q/A · filed 2022-11-25 | 290.00K shares derived: sum of 2 quarters · filed 2023-03-30 | 829.00K shares derived: sum of 3 quarters · filed 2023-03-30 | 1.11M shares derived: sum of 4 quarters · filed 2023-03-30 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 539.00K shares derived: sum of 2 quarters · filed 2023-03-30 | 824.00K shares derived: sum of 3 quarters · filed 2023-03-30 | 969.00K shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | 539.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | 824.00K shares derived: sum of 2 quarters · filed 2022-12-20 | 969.00K shares 10-Q · filed 2022-12-20 | 1.07M shares derived: sum of 4 quarters · filed 2022-12-20 | |
| 2021-06-30 | 285.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 430.00K shares 10-Q · filed 2021-08-12 | 526.67K shares derived: sum of 3 quarters · filed 2022-03-31 | 752.33K shares derived: sum of 4 quarters · filed 2022-03-31 | |
| 2021-03-31 | 145.00K shares 10-Q · filed 2021-05-17 | 241.67K shares derived: sum of 2 quarters · filed 2022-03-31 | 467.33K shares derived: sum of 3 quarters · filed 2022-03-31 | 550.67K shares derived: sum of 4 quarters · filed 2022-03-31 | |
| 2020-12-31 | 96.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 322.33K shares derived: sum of 2 quarters · filed 2022-03-31 | 405.67K shares derived: sum of 3 quarters · filed 2022-03-31 | 429.00K shares 10-K · filed 2022-03-31 | 429.01K shares 10-K · filed 2021-03-25 |
| 2020-09-30 | 225.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 309.00K shares derived: sum of 2 quarters · filed 2021-11-15 | 332.33K shares 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | 83.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 106.67K shares 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | 23.33K shares 10-Q · filed 2021-05-17 | ||||
| 2019-12-31 | 503.33K shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |